|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.57(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,971,973 |
52
Week Range: |
$10.31 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,526 |
71,026 |
3,241,429 |
7,930,135 |
Total Sell Value |
$262,322 |
$986,072 |
$41,921,797 |
$106,117,062 |
Total People Sold |
1 |
3 |
4 |
6 |
Total Sell Transactions |
1 |
5 |
18 |
31 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Burgess Justin |
Principal Accounting Officer |
|
2021-03-02 |
4/A |
S |
$8.82 |
$10,461 |
D/D |
(1,186) |
6,989 |
|
- |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-03-02 |
4 |
S |
$8.82 |
$10,275 |
D/D |
(1,165) |
7,010 |
|
-9% |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-03-01 |
4 |
S |
$8.88 |
$26,267 |
D/D |
(2,958) |
8,175 |
|
-7% |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,839 |
11,133 |
|
- |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,073 |
8,294 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2021-02-22 |
4 |
D |
$9.60 |
$103,594 |
D/D |
(10,791) |
69,620 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,833 |
80,411 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2021-02-22 |
4 |
A |
$3.39 |
$5,149 |
D/D |
1,519 |
59,578 |
|
- |
|
Novack David F |
President & COO |
|
2021-02-12 |
4 |
A |
$3.39 |
$8,475 |
D/D |
2,500 |
137,399 |
|
- |
|
Burgess Justin |
Principal Accounting Officer |
|
2021-02-12 |
4 |
A |
$3.39 |
$1,275 |
D/D |
376 |
1,221 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2021-02-01 |
4 |
AS |
$10.64 |
$448,529 |
D/D |
(42,155) |
86,485 |
|
-11% |
|
Paradiso Peter R. |
Director |
|
2020-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
112% |
|
Burgess Justin |
Principal Accounting Officer |
|
2020-08-14 |
4 |
A |
$3.39 |
$2,865 |
D/D |
845 |
845 |
|
- |
|
Novack David F |
President & COO |
|
2020-08-14 |
4 |
A |
$3.39 |
$8,475 |
D/D |
2,500 |
134,899 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2020-08-14 |
4 |
A |
$3.39 |
$5,146 |
D/D |
1,518 |
58,059 |
|
- |
|
Janssen Robert |
Senior Vice President |
|
2020-07-17 |
4 |
AS |
$11.09 |
$554,500 |
D/D |
(50,000) |
127,266 |
|
-58% |
|
Hack Andrew A. F. |
Director |
|
2020-05-27 |
4 |
B |
$5.00 |
$5,000,000 |
I/I |
1,000,000 |
8,525,000 |
2.1 |
-12% |
|
Janssen Robert |
Senior Vice President |
|
2020-05-19 |
4 |
AS |
$6.33 |
$94,950 |
D/D |
(15,000) |
177,266 |
|
15% |
|
Janssen Robert |
Senior Vice President |
|
2020-05-06 |
4 |
AS |
$4.52 |
$126,560 |
D/D |
(28,000) |
192,266 |
|
27% |
|
Janssen Robert |
Senior Vice President |
|
2020-05-05 |
4 |
AS |
$4.43 |
$39,870 |
D/D |
(9,000) |
220,266 |
|
26% |
|
Ostrach Michael S |
Senior Vice President |
|
2020-03-16 |
4 |
D |
$2.32 |
$104,254 |
D/D |
(44,937) |
117,167 |
|
- |
|
Johnson David Louis |
Vice President |
|
2020-03-13 |
4 |
D |
$2.39 |
$47,874 |
D/D |
(20,031) |
48,380 |
|
- |
|
Novack David F |
President & COO |
|
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
132,399 |
|
- |
|
Ostrach Michael S |
Senior Vice President |
|
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,500 |
162,104 |
|
- |
|
Spencer Ryan |
CEO and Director |
|
2020-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,209 |
56,541 |
|
- |
|
423 Records found
|
|
Page 7 of 17 |
|
|